Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
11.44
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
43,219
Open
11.44
Bid (Size)
11.52 (1)
Ask (Size)
11.57 (1)
Prev. Close
11.44
Today's Range
11.44 - 11.44
52wk Range
3.760 - 18.33
Shares Outstanding
303,513,872
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
October 31, 2024
Iovance also to Participate in Upcoming November Conferences
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Why Iovance Biotherapeutics Stock Triumphed on Thursday
October 24, 2024
With a cutting-edge melanoma drug now on the market, the company is positioned for a breakout.
Via
The Motley Fool
Performance
YTD
+41.23%
+41.23%
1 Month
+14.51%
+14.51%
3 Month
+54.18%
+54.18%
6 Month
-17.58%
-17.58%
1 Year
+164.81%
+164.81%
More News
Read More
Is Iovance Biotherapeutics Stock a Buy?
October 04, 2024
Via
The Motley Fool
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
September 26, 2024
Via
The Motley Fool
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
September 16, 2024
Via
The Motley Fool
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
September 03, 2024
Via
Benzinga
Looking Into Iovance Biotherapeutics's Recent Short Interest
August 16, 2024
Via
Benzinga
Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
August 12, 2024
Via
Benzinga
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
September 08, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
This Is the Biggest Risk With Iovance Biotherapeutics Stock
September 06, 2024
Via
The Motley Fool
Iovance Biotherapeutics to Present at Upcoming Conferences
September 03, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Monster Biotech Stocks to Buy Before 2025
September 02, 2024
Via
The Motley Fool
What the Options Market Tells Us About Iovance Biotherapeutics
August 08, 2024
Via
Benzinga
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
August 27, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 16, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
August 14, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Via
Benzinga
Why Iovance Biotherapeutics Shares Are Soaring Today
August 09, 2024
Via
The Motley Fool
Why Is Iovance Bio (IOVA) Stock Up 18% Today?
August 09, 2024
Via
InvestorPlace
Topics
Earnings
Exposures
Financial
Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges
August 09, 2024
Via
Benzinga
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
August 09, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
August 08, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.